CC
Casdin Capital Portfolio holdings
AUM
$1.1B
1-Year Return
24.98%
This Quarter Return
+32.81%
1 Year Return
+24.98%
3 Year Return
+152.8%
5 Year Return
+110.01%
10 Year Return
–
AUM
$123M
AUM Growth
+$27.8M
(+29%)
Cap. Flow
-$596K
Cap. Flow
% of AUM
-0.48%
Top 10 Holdings %
Top 10 Hldgs %
69.68%
Holding
31
New
6
Increased
7
Reduced
12
Closed
4
Top Buys
| 1 |
Agios Pharmaceuticals
AGIO
|
$5.02M |
| 2 |
Evolent Health
EVH
|
$3.58M |
| 3 |
Exact Sciences
EXAS
|
$2.88M |
| 4 |
MDRX
Veradigm Inc. Common Stock
MDRX
|
$2.63M |
| 5 |
GHDX
Genomic Health, Inc.
GHDX
|
$2.6M |
Top Sells
| 1 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$4.38M |
| 2 |
BLUE
bluebird bio
BLUE
|
$4.24M |
| 3 |
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
|
$4.14M |
| 4 |
Alnylam Pharmaceuticals
ALNY
|
$2.27M |
| 5 |
AVXS
AveXis, Inc. Common Stock
AVXS
|
$1.71M |
Sector Composition
| 1 | Healthcare | 82.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SYRS
26
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $694K | 0.56% |
5,000
| – | – |
|
27
Bristol-Myers Squibb
BMY
$96B
| – | – |
-21,000
| Closed | -$1.55M |
|
28
DexCom
DXCM
$31.6B
| – | – |
-60,000
| Closed | -$1.19M |
|
29
SPDR S&P Biotech ETF
XBI
$5.39B
| – | – |
0
| – | – |
|
|
TSRO
30
DELISTED
TESARO, Inc.
TSRO
| – | – |
-20,000
| Closed | -$1.68M |
|
|
AVXS
31
DELISTED
AveXis, Inc. Common Stock
AVXS
| – | – |
-45,000
| Closed | -$1.71M |
|